Norges Bank’s Aurinia Pharmaceuticals AUPH Stock Holding History

Norges Bank’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-35,532	Closed	-$260K	–	1852
2024 Q3	$260K	Sell	35,532 -78,513	-69%	-$487K	﹤0.01%	1821
2024 Q2	$651K	Hold	114,045	–	–	﹤0.01%	1857
2024 Q1	$571K	Hold	114,045	–	–	﹤0.01%	1831
2023 Q4	$1.03M	Hold	114,045	–	–	﹤0.01%	1860
2023 Q3	$886K	Hold	114,045	–	–	﹤0.01%	1898
2023 Q2	$1.1M	Hold	114,045	–	–	﹤0.01%	1923
2023 Q1	$1.25M	Hold	114,045	–	–	﹤0.01%	1980
2022 Q4	$493K	Hold	114,045	–	–	﹤0.01%	2092
2022 Q3	$858K	Hold	114,045	–	–	﹤0.01%	2017
2022 Q2	$1.15M	Buy	+114,045	New	+$1.27M	﹤0.01%	1951
2021 Q1	–	Sell	-37,966	Closed	-$525K	–	2135
2020 Q4	$525K	Hold	37,966	–	–	﹤0.01%	2075
2020 Q3	$559K	Buy	+37,966	New	+$550K	﹤0.01%	2074

Other funds holding AUPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Norges Bank's AUPH Position: Q4 2024 in Review

Norges Bank sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2024, closing a stake of 35,532 shares — an estimated $260K sold.

Norges Bank first reported a position in AUPH in Q3 2020 and held it in 12 quarters. The position peaked at $1.25M in Q1 2023. 200 funds tracked by Wall St. Rank hold AUPH as of Q4 2024.

Norges Bank reported no remaining Aurinia Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Norges Bank sold 35,532 Aurinia Pharmaceuticals shares in Q4 2024, an estimated $260K.
Norges Bank first reported a position in Aurinia Pharmaceuticals in Q3 2020 and held it in 12 quarters.
Norges Bank's Aurinia Pharmaceuticals position peaked at $1.25M in Q1 2023.
200 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2024.

Based on Norges Bank's 13F filing for Q4 2024, filed 12 Feb 2025.